• Pierre Maison-Blanche, MD, has been named chief medical officer for Biomedical Systems (St. Louis/Brussels, Belgium). In addition to his duties as Biomedical Systems’ Chief Medical Officer, Maison-Blanche serves as a Consultant for Assistance Publique des Hopitaux de Paris. In 1998, Maison-Blanche established the Centralized ECG Services Department for MDS Pharma Services in Paris, France, and chaired the MDS ECG Advisory Board from 2002-2006. Biomedical Systems is a provider of centralized diagnostic services for the pharmaceutical and medical device industries, including the acquisition, analysis and management of data for cardiac safety, imaging and pulmonary function testing.

• Delcath Systems (Stamford, Connecticut) reported that Samuel Herschkowitz, MD, has been appointed Interim COO, as the company continues its search for a new CEO and a senior VP-operations. Herschkowitz was chairman of Delcath for eight years and chief technical officer of the company for 15 years. He is currently a member of the board. Herschkowitz, board certified in psychiatry and neurology, is a professor at New York University Medical Center and has held academic positions at Beth Israel Hospital, Mount Sinai Medical School and Downstate Medical Center. Delcath is a developer of isolated perfusion technology for organ or region-specific delivery of therapeutic agents.

No Comments